Showing all 3 results

  • Sofosbuvir & Ledipasvir Tablets 

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.

    Active IngredientStrengthPrimary Clinical Function
    Sofosbuvir INN/Ph.Eur.400 mgNS5B RNA polymerase inhibition to terminate viral RNA chain synthesis.
    Ledipasvir INN/Ph.Eur.90 mgNS5A protein inhibition to halt viral replication and physical virion assembly.
    ExcipientsCopovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium StearateBinder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution)
  • Sofosbuvir & Velpatasvir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict 12-week clinical dispensing cycles.

    Active IngredientStrengthPrimary Clinical Function
    Sofosbuvir INN/Ph.Eur.400 mgNS5B RNA polymerase inhibition to terminate viral RNA chain synthesis.
    Velpatasvir INN/Ph.Eur.100 mgNS5A protein inhibition to halt viral replication and physical virion assembly.
    ExcipientsCopovidone / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium StearateBinder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution)
  • Sofosbuvir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or ultra-dense Alu-Alu blister strips to ensure the absolute chemical stability of the nucleotide analog.

    Active IngredientStrengthPrimary Clinical Function
    Sofosbuvir INN/Ph.Eur.400 mgGlobal Standard: Base NS5B polymerase inhibition for daily combination HCV therapy.
    ExcipientsMannitol / Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium StearateDiluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and high bioavailability)